SVN METHOD
LIVE

Serial Number

99855225

Owner

SVN Method LLC

Attorney

Michael D Meyer

Filing Date

May 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SVN METHOD Trademark

Serial Number: 99855225

SVN METHOD is a trademark filed by SVN Method LLC on May 30, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SVN Method LLC

1331 Columbia St Apt 2904
San Diego, CA 92101

Entity Type: 16

Trademark Details

Filing Date

May 30, 2026

Registration Date

Not Registered

Goods & Services

Medical services; Medical advisory services; Telemedicine services; Medical consultations; Medical consultations provided via phone, online chat or videoconferencing; Consulting services in the field of medical care; Providing medical information, consultancy and advisory services; Online medical consultations rendered in virtual environments; Consulting services in the field of hormone replacement therapy; Hormone replacement therapy services; Natural hormone replacement therapy services; Medical services, namely, subscription-based telehealth services; Medical services, namely, medical consultation for hormone optimization; Medical services, namely, testosterone replacement therapy (TRT); Medical services, namely, female hormone replacement therapy (HRT); Medical services, namely, thyroid optimization; Medical services, namely, weight management; Medical services, namely, GLP-1 medication management; Medical services, namely, peptide therapy; Medical services in the field of longevity medicine; Medical services in the field of metabolic health; Medical services, namely, patient education services in hormone, metabolic, weight management, and longevity wellness

Hormone replacement therapy preparations; Weight management supplements; Therapeutic pharmaceutical for the treatment of weight management; Pharmaceutical preparations for GLP-1 receptor agonists for weight management; Pharmaceutical preparations for hormone replacement therapy; Pharmaceutical preparations for compounded peptide pharmaceuticals for therapeutic use; Pharmaceutical preparations for metabolic health and longevity; Pharmaceutical preparations for subcutaneous and intramuscular injection; Pharmaceutical preparations for dietary supplements supporting hormone, metabolic, and longevity health; Pharmaceutical agents affecting metabolism

Filing History

APPLICATION FILING RECEIPT MAILED
May 30, 2026 MAFR
NEW APPLICATION ENTERED
May 30, 2026 NWAP